Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Differential coagulotoxicity of metalloprotease isoforms from Bothrops neuwiedi snake venom and consequent variations in antivenom efficacy

Texto completo
Autor(es):
Sousa, Leijiane F. [1, 2] ; Bernardoni, Juliana L. [1] ; Zdenek, Christina N. [2] ; Dobson, James [2] ; Coimbra, Francisco [2] ; Gillett, Amber [3] ; Lopes-Ferreira, Monica [4] ; Moura-da-Silva, A. M. [1] ; Fry, Bryan G. [2]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Inst Butantan, Lab Imunopatol, Sao Paulo, SP - Brazil
[2] Univ Queensland, Sch Biol Sci, Toxin Evolut Lab, Santa Lucia, Qld 4072 - Australia
[3] Fauna Vet Wildlife Vet Consultancy, Beerwah, Qld - Australia
[4] Butantan Inst, Ctr Toxins Immune Response & Cell Signaling, Immunoregulat Unit Special Lab Appl Toxinol, Sao Paulo, SP - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Toxicology Letters; v. 333, p. 211-221, OCT 15 2020.
Citações Web of Science: 0
Resumo

Bothrops (lance-head pit vipers) venoms are rich in weaponised metalloprotease enzymes (SVMP). These toxic enzymes are structurally diverse and functionally versatile. Potent coagulotoxicity is particularly important for prey capture (via stroke-induction) and relevant to human clinical cases (due to consumption of clotting factors including the critical depletion of fibrinogen). In this study, three distinct isoforms of P-III class SVMPs (IC, IIB and IIC), isolated from Bothrops neuwiedi venom, were evaluated for their differential capacities to affect hemostasis of prey and human plasma. Furthermore, we tested the relative antivenom neutralisation of effects upon human plasma. The toxic enzymes displayed differential procoagulant potency between plasma types, and clinically relevant antivenom efficacy variations were observed. Of particular importance was the confirmation the antivenom performed better against prothrombin activating toxins than Factor X activating toxins, which is likely due to the greater prevalence of the former in the immunising venoms used for antivenom production. This is clinically relevant as the enzymes displayed differential potency in this regard, with one (IC) in particular being extremely potent in activating Factor X and thus was correspondingly poorly neutralised. This study broadens the current understanding about the adaptive role of the SVMPs, as well as highlights how the functional diversity of SVMP isoforms can influence clinical outcomes. Key Contribution: Our findings shed light upon the hemorrhagic and coagulotoxic effects of three SVMPs of the P-III class, as well as the coagulotoxic effects of SVMPs on human, avian and amphibian plasmas. Antivenom neutralised prothrombin-activating isoforms better than Factor X activating isoforms. (AU)

Processo FAPESP: 12/23018-0 - Vantagens adaptativas da presença de diferentes metaloproteinases na composição dos venenos botrópicos e implicações dessa variabilidade nos acidentes ofídicos
Beneficiário:Juliana Lech Bernardoni
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 17/15170-0 - Caracterização de mecanismos envolvidos nos distúrbios hemostáticos induzidos por venenos de Bothrops atrox de três locais da Amazônia Brasileira
Beneficiário:Leijiane Figueira de Sousa
Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Doutorado
Processo FAPESP: 14/13124-2 - Variabilidade em venenos de serpentes Bothrops atrox no oeste do Pará: implicações ecológicas e para a fisiopatologia dos envenenamentos
Beneficiário:Leijiane Figueira de Sousa
Modalidade de apoio: Bolsas no Brasil - Doutorado